America Great Health (AAGH) financial statements (2020 and earlier)

Company profile

Business Address 1609 W VALLEY BLVD UNIT 338A
ALHAMBRA, CA 91803
State of Incorp. CA
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments04924 39
Cash and cash equivalents04924 39
Receivables00    
Other undisclosed current assets  240  (20)
Total current assets:0424924 20
Noncurrent Assets
Long-term investments and receivables13     
Long-term investments13     
Other undisclosed noncurrent assets     0
Total noncurrent assets:13    0
TOTAL ASSETS:13424924 20
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:208481910
Accounts payable  481910
Accrued liabilities 8    
Other undisclosed accounts payable and accrued liabilities20     
Due to related parties1014412040030 
Other undisclosed current liabilities  51  50
Total current liabilities:121521754813960
Noncurrent Liabilities
Other undisclosed noncurrent liabilities   535  
Total noncurrent liabilities:   535  
Total liabilities:121521751,0173960
Stockholders' equity
Stockholders' equity attributable to parent, including:(107)(48)(1,093)(998)(353)(227)
Preferred stock  500   
Common stock     49
Common stock, share subscribed but unissued, subscriptions receivable     87
Additional paid in capital3,0623,062550   
Retained earnings (accumulated deficit)(3,170)(3,110)(2,143)(998)(353)189
Other undisclosed stockholders' equity attributable to parent     (553)
Other undisclosed stockholders' equity   5  
Total stockholders' equity:(107)(48)(1,093)(992)(353)(227)
Other undisclosed liabilities and equity  1,168  188
TOTAL LIABILITIES AND EQUITY:13424924(315)20

Income statement (P&L) ($ in thousands)

6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues
(Revenue, Net)
  3,17443 7
Cost of revenue
(Cost of Goods and Services Sold)
  (2,959)(59)  
Gross profit:  216(16) 7
Operating expenses(58)(48)(123)   
Operating income (loss):(58)(48)93(16) 7
Nonoperating expense(0)     
Foreign currency transaction loss, before tax(1)     
Interest and debt expense  55  1
Income (loss) from continuing operations before income taxes:(59)(48)148(16) 8
Income tax expense(1)     
Income (loss) from continuing operations:(59)(48)148(16) 8
Loss from discontinued operations (919)    
Net income (loss):(59)(967)148(16) 8
Net income attributable to noncontrolling interest  10   
Other undisclosed net loss attributable to parent  (1,309)(629) (117)
Net loss attributable to parent:(59)(967)(1,151)(645) (109)
Other undisclosed net income available to common stockholders, basic  10   
Net loss available to common stockholders, diluted:(59)(967)(1,141)(645) (109)

Comprehensive Income ($ in thousands)

6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net income (loss):(59)(967)148(16) 8
Comprehensive income (loss):(59)(967)148(16) 8
Comprehensive income, net of tax, attributable to noncontrolling interest  10   
Comprehensive income (loss), net of tax, attributable to parent:(59)(967)158(16) 8

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: